Checkmate: Metabolic flexibility with a STING in its tail

Authors: Roddy S. O’Connor

Published: 2023-12-06

DOI: 10.1126/sciadv.adm6816

Source: Full article


Abstract

Inhibiting a key metabolic enzyme, ACLY, in cancer cells impacts T cell function in immunotherapy-resistant tumors and may offer a target for therapeutic treatment.